NumFin

Diaceutics PLC

符号: DIUXF

PNK

1.3672

USD

今天的市场价格

  • -124.8659

    市盈率

  • 2.7906

    PEG比率

  • 123.70M

    MRK市值

  • 0.00%

    DIV收益率

Diaceutics PLC (DIUXF) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Diaceutics PLC (DIUXF). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Diaceutics PLC 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016

balance-sheet.row.cash-and-short-term-investments

019.819.725.3
11.7
2.1
3.1
1.3

balance-sheet.row.short-term-investments

0000
0
0
0
0

balance-sheet.row.net-receivables

010.4107.8
6.4
0
0
0

balance-sheet.row.inventory

0000
0
0
0
0

balance-sheet.row.other-current-assets

00.60.40.6
0.3
0
0
0

balance-sheet.row.total-current-assets

030.930.133.6
18.4
6.5
4.8
3.2

balance-sheet.row.property-plant-equipment-net

02.12.10.2
0.1
0.1
0
0

balance-sheet.row.goodwill

0000
0
0
0
0

balance-sheet.row.intangible-assets

015.212.89.4
3.8
1.2
0.5
0

balance-sheet.row.goodwill-and-intangible-assets

015.212.89.4
3.8
1.2
0.5
0

balance-sheet.row.long-term-investments

017.114.79.2
1.5
0
0
0

balance-sheet.row.tax-assets

0000.3
0.1
0.1
0.1
0.2

balance-sheet.row.other-non-current-assets

0-17.1-14.7-9.2
-1.5
0
0
0

balance-sheet.row.total-non-current-assets

017.4159.9
4
1.3
0.7
0.2

balance-sheet.row.other-assets

0000
0
0
0
0

balance-sheet.row.total-assets

048.34543.5
22.4
7.8
5.5
3.4

balance-sheet.row.account-payables

00.80.50.5
2.1
0.2
0.2
0.1

balance-sheet.row.short-term-debt

00.10.30.1
0.1
2.7
0.5
0.4

balance-sheet.row.tax-payables

00.40.30.8
0
0.1
0.1
0.1

balance-sheet.row.long-term-debt-total

01.21.30
0
1.1
1.6
1

Deferred Revenue Non Current

00-0.40
0
0.2
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-

balance-sheet.row.other-current-liab

02.51.62
-0.4
1
1.3
0.9

balance-sheet.row.total-non-current-liabilities

021.70.4
0
1.2
1.6
1

balance-sheet.row.other-liabilities

0000
0
0
0
0

balance-sheet.row.capital-lease-obligations

01.31.40
0
0
0
0

balance-sheet.row.total-liab

05.74.43.3
2.2
5.2
3.6
2.4

balance-sheet.row.preferred-stock

000.30
0
0
0
0

balance-sheet.row.common-stock

00.20.20.2
0.1
0
0
0

balance-sheet.row.retained-earnings

05.34.13.2
2.6
2.2
1.5
0.7

balance-sheet.row.accumulated-other-comprehensive-income-loss

00.1-0.30
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

036.936.436.9
17.3
0.4
0.4
0.3

balance-sheet.row.total-stockholders-equity

042.540.640.2
20.1
2.6
1.9
1

balance-sheet.row.total-liabilities-and-stockholders-equity

048.34543.5
22.4
7.8
5.5
3.4

balance-sheet.row.minority-interest

0000
0
0
0
0

balance-sheet.row.total-equity

042.540.640.2
20.1
2.6
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-

Total Investments

017.114.79.2
1.5
0
0
0

balance-sheet.row.total-debt

01.31.60.1
0.1
3.7
2.1
1.4

balance-sheet.row.net-debt

0-18.5-18.1-25.1
-11.6
1.7
-1
0.2

现金流量表

在 Diaceutics PLC 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016

cash-flows.row.net-income

00.60.5-0.7
0.5
0.9
0.8
0.8

cash-flows.row.depreciation-and-amortization

031.80.8
0.3
0.1
0
0.2

cash-flows.row.deferred-income-tax

01.3-0.5-0.7
-0.2
-0.2
-0.1
-0.1

cash-flows.row.stock-based-compensation

00.50.40.3
0
0.4
0.1
0.2

cash-flows.row.change-in-working-capital

0-0.3-1.70.5
-1.5
-2.5
0.6
-0.5

cash-flows.row.account-receivables

0-1.6-1.50.5
-2.3
0
0
0

cash-flows.row.inventory

0000
0
0
0
0

cash-flows.row.account-payables

01.3-0.2-0.1
0.8
0
0
0

cash-flows.row.other-working-capital

0000
0
0
0
0

cash-flows.row.other-non-cash-items

000.10
0.2
0.3
0
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-4.9-5.6-6.3
-2.9
-1.1
-0.3
0

cash-flows.row.acquisitions-net

0000
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0

cash-flows.row.other-investing-activites

00.100
0
0
-0.2
0

cash-flows.row.net-cash-used-for-investing-activites

0-4.8-5.6-6.3
-2.9
-1.1
-0.3
0

cash-flows.row.debt-repayment

00-0.10
-3.5
-0.6
-0.4
-0.2

cash-flows.row.common-stock-issued

00.1019.6
16
0
0
0

cash-flows.row.common-stock-repurchased

0-0.1-0.20
0
0
0
-0.1

cash-flows.row.dividends-paid

0000
0
-0.3
0
0

cash-flows.row.other-financing-activites

0-0.200
0.7
1.9
0.9
0.5

cash-flows.row.net-cash-used-provided-by-financing-activities

0-0.2-0.319.6
13.3
1
0.5
0.2

cash-flows.row.effect-of-forex-changes-on-cash

00-0.30
-0.1
0
0
0

cash-flows.row.net-change-in-cash

00.2-5.613.5
9.6
-1
1.8
0.9

cash-flows.row.cash-at-end-of-period

019.819.725.3
11.7
2.1
3.1
1.3

cash-flows.row.cash-at-beginning-of-period

019.725.311.7
2.1
3.1
1.3
0.4

cash-flows.row.operating-cash-flow

05.10.60.3
-0.6
-1
1.5
0.7

cash-flows.row.capital-expenditure

0-4.9-5.6-6.3
-2.9
-1.1
-0.3
0

cash-flows.row.free-cash-flow

00.2-5-6
-3.6
-2.1
1.3
0.6

利润表行

Diaceutics PLC 的收入与上期相比变化了 NaN%。据报告, DIUXF 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016

income-statement-row.row.total-revenue

019.513.912.7
13.4
10.4
7.4
4.6

income-statement-row.row.cost-of-revenue

02.83.23.2
3.1
3.6
2.5
1.9

income-statement-row.row.gross-profit

016.710.79.5
10.3
6.8
4.9
2.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.other-expenses

0000
0
0
0
0

income-statement-row.row.operating-expenses

016.210.29.7
8.2
5.4
4
1.8

income-statement-row.row.cost-and-expenses

018.913.413
11.4
9
6.5
3.7

income-statement-row.row.interest-income

00.10.10
0
0
0
0

income-statement-row.row.interest-expense

00.10.10
0.2
0.3
0.1
0.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.total-other-income-expensenet

00-0.10
-0.2
-0.3
-0.1
-0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
0
0
0

income-statement-row.row.total-operating-expenses

00-0.10
-0.2
-0.3
-0.1
-0.1

income-statement-row.row.interest-expense

00.10.10
0.2
0.3
0.1
0.1

income-statement-row.row.depreciation-and-amortization

031.80.8
0.3
0.1
0
0.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-

income-statement-row.row.operating-income

00.60.6-0.7
0.7
1.2
0.9
0.9

income-statement-row.row.income-before-tax

00.60.5-0.7
0.5
0.9
0.8
0.8

income-statement-row.row.income-tax-expense

0-0.2-0.1-0.9
0.1
0.2
0.1
0

income-statement-row.row.net-income

00.70.60.3
0.4
0.6
0.7
0.7
类似股票
您可能还对以下内容感兴趣：
THYROCARE.BO
Thyrocare Technologies Limited.
605.85 INR
BSE
HTGM
HTG Molecular Diagnostics, Inc..
0.48 USD
NASDAQ
CO
Global Cord Blood Corporation.
2.9876 USD
NYSE
ANPCF
ANGLE plc.
0.16678 USD
PNK
MYGN
Myriad Genetics, Inc..
21.6 USD
NASDAQ
CNTG
Centogene N.V..
0.71 USD
NASDAQ
DMTK
DermTech, Inc..
0.6906 USD
NASDAQ
HTGMQ
HTG Molecular Diagnostics, Inc..
0.0015 USD
PNK
SQIDF
SQI Diagnostics Inc..
0.0149 USD
PNK

常见问题

什么是 Diaceutics PLC (DIUXF) 总资产是多少？

Diaceutics PLC (DIUXF) 总资产为 48256000.000.

什么是企业年收入？

年收入为 N/A.

企业利润率是多少？

公司利润率为 0.796.

什么是公司自由现金流？

自由现金流为 -0.027.

什么是企业净利润率？

净利润率为 -0.027.

企业总收入是多少？

总收入为 -0.061.

什么是 Diaceutics PLC (DIUXF) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 724000.000.

公司总债务是多少？

债务总额为 1329000.000.

营业费用是多少？

运营支出为 16166000.000.

公司现金是多少？

企业现金为 0.000.